Feature Channels: Respiratory Diseases and Disorders

Filters close
Newswise: On Inaugural World Bronchiectasis Day, International Lung Health Organizations Raise Awareness
Released: 1-Jul-2022 8:00 AM EDT
On Inaugural World Bronchiectasis Day, International Lung Health Organizations Raise Awareness
American Thoracic Society (ATS)

In support of the first World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies – of which the American Thoracic Society is a founding member – is joining the COPD Foundation and several global organizations in raising awareness and sharing information about this lesser-known lung disease.

Newswise: Awake prone positioning does not offer benefit in reducing intubation for COVID-19 induced acute respiratory failure
Released: 29-Jun-2022 11:35 AM EDT
Awake prone positioning does not offer benefit in reducing intubation for COVID-19 induced acute respiratory failure
University of Texas Health Science Center at Houston

A large multicenter, randomized clinical trial revealed no difference in the risk of endotracheal intubation requirement at 30 days between awake prone positioning and standard positioning for patients with COVID-19 who suffered from acute hypoxemic respiratory failure, according to research published in JAMA by researchers at UTHealth Houston.

Newswise: $5.3 Million Grant Supports Research Into Lung Cancer Recurrence
Released: 28-Jun-2022 4:05 PM EDT
$5.3 Million Grant Supports Research Into Lung Cancer Recurrence
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis are leading a national study aimed at identifying patients with early-stage lung cancer who are at high risk of having the cancer return, even after surgery and chemotherapy appear to have eliminated their tumors. The research is supported by a $5.3 million grant from the National Cancer Institute of the National Institutes of Health (NIH).

Released: 28-Jun-2022 9:00 AM EDT
Drug Repurposing Identifies New Candidates to Treat Mesothelioma
Sbarro Health Research Organization (SHRO)

A group of researchers have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM).

Released: 27-Jun-2022 3:00 PM EDT
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
Sbarro Health Research Organization (SHRO)

There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting.

Released: 23-Jun-2022 3:00 PM EDT
FDA Removes Juul from U.S. Market – An Important, But Temporary, Decision
American Thoracic Society (ATS)

The American Thoracic Society applauds the FDA’s decision to remove Juul products from the U.S. marketplace. This decision is long overdue.

Released: 22-Jun-2022 1:00 PM EDT
Getting Tough on Tuft Cell Lung Cancer
Cold Spring Harbor Laboratory

Cold Spring Harbor Laboratory (CSHL) Professor Christopher Vakoc’s team discovered in 2018 a new type of small-cell lung cancer. The cancer originates from cells known as tuft cells.

Newswise: Effect of Dust and Smoke on Western Drought ‘Likely Similar’ to African Study, Author Says
Released: 22-Jun-2022 10:00 AM EDT
Effect of Dust and Smoke on Western Drought ‘Likely Similar’ to African Study, Author Says
University of Alabama Huntsville

A University of Alabama in Huntsville (UAH) student says his examination of the combined influence of dust and smoke on surface atmosphere temperatures in sub-Saharan Africa likely applies to conditions in the American West, now in its worst drought in over 1,200 years.

Newswise: Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Released: 21-Jun-2022 8:00 AM EDT
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
University of California, San Francisco (UCSF)

Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.

Newswise: UTSW Scientists Identify Protein Key to Inhibiting Flu Virus
Released: 20-Jun-2022 1:15 PM EDT
UTSW Scientists Identify Protein Key to Inhibiting Flu Virus
UT Southwestern Medical Center

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands. The findings were published in PNAS.

Released: 20-Jun-2022 12:35 PM EDT
فيروس كورونا المستجد طويل الأمد والجهاز الهضمي: خبير مايو كلينك يصف الأعراض الشائعة
Mayo Clinic

إن متلازمة فيروس كورونا المستجد طويل الأمد، والمعروفة باسم متلازمة ما بعد فيروس كورونا المستجد، أكثر من مجرد الإرهاق وضيق النفس. حيث تم الإبلاغ عن أعراض مثل: الصداع وضباب الدماغ وطنين الأذنين، ومؤخرًا، يرى الأطباء المزيد من المرضى يعانون من مشاكل في الجهاز الهضمي.

Released: 20-Jun-2022 12:25 PM EDT
COVID longa e sistema digestivo: especialista da Mayo Clinic descreve os sintomas comuns
Mayo Clinic

A síndrome da COVID longa, também conhecida como pós-COVID, é mais que cansaço e falta de ar. Sintomas como dores de cabeça, confusão mental e zumbido nos ouvidos foram relatados e, recentemente, os médicos estão atendendo mais pacientes com problemas gastrointestinais.

Released: 20-Jun-2022 12:25 PM EDT
COVID prolongada y sistema digestivo: experto de Mayo Clinic describe los síntomas frecuentes
Mayo Clinic

El síndrome de COVID prolongada, también conocido como síndrome poscovid, es más que sentir cansancio y falta de aire. Se ha informado también sobre síntomas como dolores de cabeza, bruma mental, tintineo en los oídos y, últimamente, los médicos ven más pacientes con problemas gastrointestinales.

Released: 16-Jun-2022 10:35 AM EDT
A Decade Later, Some Veterans Find It Hard to Breathe
Michigan Medicine - University of Michigan

A decade after the conflicts in Iraq and Afghanistan, some veterans find themselves with mysterious lung issues, seemingly attributable to exposure to burn pits.

13-Jun-2022 3:35 PM EDT
New Lung-Cancer Screening Guidelines Reduce Disparity
Thomas Jefferson University

Cancer screening guidelines published last year expand eligibility for those at high risk for lung cancer, and new research shows that they also improve representation among African American patients.

Released: 14-Jun-2022 3:15 PM EDT
"Yes, optimists live longer" and more research news on Aging for media
Newswise

Here are some of the latest articles that have been added to the Aging channel on Newswise, a free source for journalists.

Released: 14-Jun-2022 1:05 PM EDT
UCI-Led Study Finds Prolonged, Low-Level Radon Exposure Still a Leading Cause of Lung Cancer
University of California, Irvine

A study led by the University of California, Irvine  shows a strong relationship between prolonged exposure to low levels of radon and lung cancer, indicating a need for enhanced protection measures.  Radon gas in the air decays into tiny radioactive particles which can damage lung cells and lead to cancer.

Newswise: Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
9-Jun-2022 12:05 AM EDT
Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
McMaster University

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

Newswise: Pitt researchers led the largest-ever series of phage therapy case studies
Released: 9-Jun-2022 12:20 PM EDT
Pitt researchers led the largest-ever series of phage therapy case studies
University of Pittsburgh

In a new paper published today in the journal Clinical Infectious Diseases, a team led by researchers from the University of Pittsburgh and the University of California San Diego report 20 new case studies on the use of the experimental treatment, showing the therapy’s success in more than half of the patients.

Released: 9-Jun-2022 11:05 AM EDT
Rensselaer Professor Amir Hirsa To Track Physical and Virtual Virus Across Liquid Lining of the Lungs
Rensselaer Polytechnic Institute (RPI)

A new project from Rensselaer Polytechnic Institute to develop a predictive model for how tiny virus particles behave in the lungs holds the potential to significantly impact COVID research. The fluid dynamics proposal was recently awarded a three-year National Science Foundation grant for $298,000.

Newswise: Zinc Found to Play an Important Role in Lung Fibrosis
Released: 8-Jun-2022 1:05 PM EDT
Zinc Found to Play an Important Role in Lung Fibrosis
Cedars-Sinai

Investigators from the Women’s Guild Lung Institute at Cedars-Sinai have discovered that zinc, a common mineral, may reverse lung damage and improve survival for patients with a deadly age-related condition known as idiopathic pulmonary fibrosis (IPF).

Released: 3-Jun-2022 3:05 PM EDT
Targeted Drug Achieves 43% Response Rate in KRAS-mutated Lung Cancer
Dana-Farber Cancer Institute

Nearly 43% of patients with non-small cell lung cancer (NSCLC) whose lung cancers harbored a specific KRAS mutation responded to the experimental drug adagrasib, and the targeted agent also showed activity against lesions in the brain that metastasized from the lung tumors, according to results of a study led by Dana-Farber Cancer Institute investigators.

Released: 3-Jun-2022 11:05 AM EDT
Researchers Establish a Profile of the COVID-19 Deceased Based on the Analysis of 140 Cases of Complete Autopsies
University of Malaga

Men aged between 60 and 77 with Diffuse Alveolar Damage (DAD) –acute lung injury– in proliferative phase.

1-Jun-2022 10:05 AM EDT
Biomarker in Liquid Biopsy for Lung Cancer Appears More Accurate in Predicting Immunotherapy Response Than Tumor Biopsy
Mount Sinai Health System

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure. Their study was published in the Journal of Experimental & Clinical Cancer Research in June.

Released: 1-Jun-2022 8:30 AM EDT
Blocking Enzyme Could Hold the Key to Preventing, Treating Severe COVID-19
Ohio State University

Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing inflammation, tissue injury and blood clots in the lungs, new research in mice suggests.

Released: 31-May-2022 11:05 AM EDT
UCLA Neuroscientists Use Electrical Stimulation to Restore Breathing in Surgery Patients Undergoing Opioid-Based Anesthesia
University of California, Los Angeles (UCLA), Health Sciences

New UCLA research published in The Journal of Physiology points to a novel treatment for respiratory depression associated with opioid use that administers electrical pulses to the back of the neck, helping patients regain respiratory control following high dosage opioid use. This could offer an alternative to pharmacological treatments, which can cause withdrawal symptoms, heart problems and can negatively affect the central nervous system.

Newswise: FIRS Partners Address Tobacco Industry for World No Tobacco Day
Released: 31-May-2022 8:05 AM EDT
FIRS Partners Address Tobacco Industry for World No Tobacco Day
American Thoracic Society (ATS)

On World No Tobacco Day, May 31, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a member, is voicing concerns over the tobacco industry’s impact on environmental health and ultimately lung health.

Newswise: Funding From the Gerber Foundation Fueled Dr. Christopher Russell’s Research Into Bacterial Tracheostomy-Associated Respiratory Infections
Released: 31-May-2022 6:05 AM EDT
Funding From the Gerber Foundation Fueled Dr. Christopher Russell’s Research Into Bacterial Tracheostomy-Associated Respiratory Infections
Children's Hospital Los Angeles

Each year, nearly 4,000 children undergo a tracheostomy, the surgical placement of a breathing tube, and many experience bacterial respiratory infections. Despite the frequency of infections, there are no guidelines for how to prevent, diagnose or treat patients.

Released: 30-May-2022 1:05 PM EDT
Scientists Solve Long-Standing Mystery: Why Do Some Asthma Patients Respond Poorly to Treatment?
Rutgers University-New Brunswick

Patients with the most severe form of asthma produce special substances in their airways when taking medicine during an asthma attack that block the treatment from working, according to a study where Rutgers scientists collaborated with researchers at Genentech, a member of the Roche Group.

19-May-2022 3:45 PM EDT
Asymptomatic SARS-CoV-2 infections responsible for spreading of COVID-19 less than symptomatic infections
PLOS

Review of 130 different studies finds proportion of asymptomatic infection 50% or lower in most studies.

Released: 26-May-2022 1:05 PM EDT
Prone positioning may not be helpful for all awake hypoxemic COVID-19 patients
McMaster University

At the beginning of the COVID-19 pandemic, prone positioning was believed to be a potentially useful intervention – one that warranted further investigation. While some studies suggested awake prone positioning was safe, there was insufficient evidence to recommend using this strategy in clinical guidelines. COVI-PRONE, designed to provide robust evidence, included 21 hospitals in Canada, Saudi Arabia, Kuwait, and the United States. Researchers aimed to use prone positioning in hypoxemic COVID-19 patients for 8 to 10 hours per day, with 2 to 3 breaks, as needed. Participants in the control group were not proned and were asked not to position themselves in the prone position.

Released: 24-May-2022 2:50 PM EDT
Stem Cell Cloning Experts Unraveling Cystic Fibrosis
University of Houston

Two nationally recognized experts in cloning and stem cell science from the University of Houston are taking the first step toward limiting the consequences of chronic inflammation in cystic fibrosis (CF) by identifying the source of this persistent and enigmatic inflammation in CF lungs.

Released: 20-May-2022 4:40 PM EDT
Respiratory Syncytial Virus (RSV) responsible for more than 100,000 deaths worldwide in children under five in 2019
Lancet

Acute lower respiratory infection caused by Respiratory Syncytial Virus (RSV) contributes substantially to the global mortality burden in children, with RSV estimated to cause one in 50 deaths among children under five, and one in 28 deaths among children under six months.

Newswise: In STOP-COVID19 Trial, Brensocatib Did Not Improve Condition of Patients with Severe COVID-19
9-May-2022 4:00 PM EDT
In STOP-COVID19 Trial, Brensocatib Did Not Improve Condition of Patients with Severe COVID-19
American Thoracic Society (ATS)

Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind randomized, placebo-controlled STOP-COVID19 multicenter clinical trial, according to research published at the ATS 2022 international conference.

Newswise: Penn Medicine Study Reveals Imaging Approach with Potential to Detect Lung Cancer Earlier, at the Cellular Level
Released: 18-May-2022 9:55 AM EDT
Penn Medicine Study Reveals Imaging Approach with Potential to Detect Lung Cancer Earlier, at the Cellular Level
Perelman School of Medicine at the University of Pennsylvania

Researchers at the Abramson Cancer Center at the University of Pennsylvania have found a way to identify lung cancer at the cellular level in real time during a biopsy, offering promise in the ability to detect the disease earlier and with more confidence. The research is published this week in Nature Communications.

9-May-2022 4:00 PM EDT
Substudy of ADVOCATE Trial for ANCA-Associated Vasculitis Finds Avacopan Reduces Need for Glucocorticoids, Respiratory and ENT Involvement
American Thoracic Society (ATS)

Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement and enabled reduced glucocorticoid use in ANCA-associated vasculitis patients participating in the phase 3 ADVOCATE trial. Study results were published at the ATS 2022 international conference. The study was a subgroup analysis of results from the larger trial, which led to FDA approval of avacopan.

Newswise: Nearly Half of Patients at High Risk for Lung Cancer Delayed Screening Follow-Up
9-May-2022 4:00 PM EDT
Nearly Half of Patients at High Risk for Lung Cancer Delayed Screening Follow-Up
American Thoracic Society (ATS)

The first study to look at follow-up for patients deemed at high risk for lung cancer after CT screening found that 47 percent delayed follow-up care, according to research published at the ATS 2022 international conference.

Newswise: American Thoracic Society Announces Leadership for 2022-2023
Released: 17-May-2022 5:05 PM EDT
American Thoracic Society Announces Leadership for 2022-2023
American Thoracic Society (ATS)

Today at its annual Membership Meeting, the slate of officers to serve on the American Thoracic Society’s Executive Committee for the 2021-2022 term were approved by the membership.

Released: 17-May-2022 3:30 PM EDT
World-first study reveals why people with COPD are more susceptible to COVID-19
Centenary Institute

Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19.

Newswise: UC Davis Health performs first robotic-assisted bronchoscopy procedure
Released: 17-May-2022 11:50 AM EDT
UC Davis Health performs first robotic-assisted bronchoscopy procedure
UC Davis Health

UC Davis Health physicians have performed the first single anesthesia diagnosis to treatment of lung cancer utilizing a fully robotic approach in the UC Health System. Procedure allows physicians to diagnose and remove lung cancer mass during single surgery.

4-May-2022 8:30 PM EDT
Early Results of an International Trial Indicate that Robotic-Assisted Lobectomy is a Cost-Effective Intervention Associated with Better Patient-Reported Health-Related Quality of Life
American Association for Thoracic Surgery (AATS)

In comparison to data about video-assisted (VATS) lobectomy, retrospective data about robotic-assisted (RTS) lobectomies show such benefits as decreased postoperative pain, lower mortality, shorter chest tube duration, shorter hospital stays, and reduced incidences of postoperative pulmonary complications.

Released: 17-May-2022 9:05 AM EDT
Pulmonary Fibrosis Foundation Expands Clinical Trial Resources for Patients
Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation (PFF) has developed new materials and tools for people living with pulmonary fibrosis (PF) to learn about and enroll in clinical research studies.

Newswise: NAVIGATOR Data Show Half of Patients with Severe, Uncontrolled Asthma Improved with Tezepelumab Therapy
9-May-2022 4:00 PM EDT
NAVIGATOR Data Show Half of Patients with Severe, Uncontrolled Asthma Improved with Tezepelumab Therapy
American Thoracic Society (ATS)

A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international conference. The study showed that nearly half of those enrolled achieved complete response to treatment across measures of exacerbation reduction, asthma control, lung function, and clinician assessment.

4-May-2022 4:20 PM EDT
Study Finds That Using Cold Static Preservation at 10°C is an Effective, Reliable Strategy to Improve the Logistics of Lung Transplants
American Association for Thoracic Surgery (AATS)

A study presented today at the AATS 102nd Annual Meeting reports that intentionally prolonging the cold static preservation (CSP) of a donor lung at 10°C (12-24h) is clinically safe and feasible.

Released: 16-May-2022 9:00 AM EDT
Pulmonary Fibrosis Foundation Research Explores Quality and Access to Patient Care
Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation announced research results from four studies examining access to care and outcomes for patients living with pulmonary fibrosis and interstitial lung disease.

Newswise: Many Black Men with “Normal” Lung Function May Actually Have Emphysema
9-May-2022 4:00 PM EDT
Many Black Men with “Normal” Lung Function May Actually Have Emphysema
American Thoracic Society (ATS)

A significant percentage of Black men found to have normal lung function after race-based adjustments to spirometry were actually found to have emphysema on their computed tomography (CT) scans, according to research published at the ATS 2022 international conference.

Newswise: New Study Reports Need to Monitor Public Interest in Shopping and Sales of Popular Puff Bar E-cigarette Brand
11-May-2022 1:25 PM EDT
New Study Reports Need to Monitor Public Interest in Shopping and Sales of Popular Puff Bar E-cigarette Brand
American Cancer Society (ACS)

New research led by scientists at the American Cancer Society shows the need for continued surveillance of the changes in shopping interest and sales for Puff Bar, the most preferred brand of electronic cigarettes or e-cigarettes among youth in the United States. Public interest in shopping and sales of Puff Bar skyrocketed in 2020.

9-May-2022 10:25 AM EDT
Common steroids after ‘long Covid’ recovery may cut risk of death by up to 51%
Frontiers

Researchers show that severe inflammation during hospitalization for Covid-19 increases risk of death within one year from seeming recovery by 61%. This risk is mitigated if anti-inflammatory steroids are prescribed upon discharge. We need to think of Covid-19 as a potentially chronic disease that requires long-term management, argue the authors.

Newswise: New Research in JNCCN Encourages Harnessing Health Technology to Help Cancer Patients Quit Smoking
10-May-2022 4:05 PM EDT
New Research in JNCCN Encourages Harnessing Health Technology to Help Cancer Patients Quit Smoking
National Comprehensive Cancer Network® (NCCN®)

A new study in JNCCN finds patients with cancer who smoke are more likely to receive evidence-based cessation assistance by using the ELEVATE program, increasing the likelihood of better outcomes.

Released: 10-May-2022 2:55 PM EDT
Exposure to wildfires increases risk of cancer
McGill University

A new study from McGill University finds higher incidence of lung cancer and brain tumors in people exposed to wildfires.


Showing results

150 of 2712

close
1.03333